Supporting Confidence During Angiographic Procedures
In angiography, Bayer prioritizes the operator experience by bringing intuitive design, ergonomic flexibility and technical expertise to support procedural confidence. Backed by on-site training, our approach helps you optimize your workflow from day one.

MEDRAD® Mark 7 Arterion Injection System
Optimizes workflow control and maneuverability with ergonomic design and intuitive operation to support efficient angiography procedures in your busy cardiovascular suites.
MEDRAD® Mark V ProVis End of Life (EOL)
The MEDRAD® Mark V ProVis Injection System reached EOL in the US on December 31, 2025. Bayer is here to support your next steps, including upgrade pathways to the MEDRAD® Mark 7 Arterion Injection System.



